Market Research Logo

Global Autism Disorder Treatment Market Analysis 2018 - Forecast to 2025

Global Autism Disorder Treatment Market Analysis 2018 - Forecast to 2025

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next eight years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This research report analyzes the global markets with in-depth insights. The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K., Spain and ROE), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC), South America (Argentina, Brazil, Venezuela, Chile, and Peru) and Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, and Rest of MEA). Annual estimations and forecasts are provided from the year 2014 to 2025 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:

  • Market Sizing estimations and forecasts across the given market segments
  • Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities, )
  • Strategic recommendations in key business segments based on the market estimations
  • Regional and country level market analysis
  • Competitive landscaping of major market players
  • Company profiling covering the financials, recent activities and the future strategies


1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations
2 Executive Summary
3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Autism Disorder Treatment Market by Type
5.1 Introduction
5.2 Pervasive Developmental Disorder
5.3 Asperger Syndrome
5.4 Other Types
6 Autism Disorder Treatment Market by Treatment Type
6.1 Introduction
6.2 Oxytocin therapy
6.3 Hyperbaric oxygen therapy
6.4 Chelation therapy
6.5 ABA (applied behavioral analysis)
6.6 Other Treatment Types
7 Autism Disorder Treatment Market by Drug
7.1 Introduction
7.2 Stimulants
7.3 Selective Serotonin Reuptake Inhibitors (SSRIs)
7.4 Anti-Convulsants
7.5 Anti-Psychotic
7.5.1 Risperidone
7.5.2 Abilify (aripiprazole)
8 Geographical Segmentation
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 South America
8.4.1 Argentina
8.4.2 Brazil
8.4.3 Venezuela
8.4.4 Chile
8.4.5 Peru
8.5 Middle East & Africa
8.5.1 UAE
8.5.2 Saudi Arabia
8.5.3 Qatar
8.5.4 Iran
8.5.5 South Africa
8.5.6 Rest of MEA
9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiles
10.1 Teva Pharmaceutical Industries Ltd.
10.2 Sun Pharmaceutical Industries Ltd.
10.3 Pfizer Inc.
10.4 Otsuka Holdings Co. Ltd
10.5 Novartis AG
10.6 Merck & Co. Inc
10.7 Johnson & Johnson Services, Inc.
10.8 Eli Lilly And Company
10.9 Consern Pharma Private Limited
10.10 Bristol-Myers Squibb Company
10.11 Allergan, Plc
10.12 Coronis Partners Ltd.
10.13 Curemark LLC
10.14 Heptares Therapeutics Limited
10.15 Intra-Cellular Therapies Inc.
11 Appendix
12 Disclaimer
List of Tables
Table 1 Global Autism Disorder Treatment Market Analysis, by Region, (2016-2025) ($MN)
Table 2 Global Autism Disorder Treatment Market Analysis, by Type, (2016-2025) ($MN)
Table 3 Global Autism Disorder Treatment Market Analysis, by Pervasive Developmental Disorder, (2016-2025) ($MN)
Table 4 Global Autism Disorder Treatment Market Analysis, by Asperger Syndrome, (2016-2025) ($MN)
Table 5 Global Autism Disorder Treatment Market Analysis, by Other Types, (2016-2025) ($MN)
Table 6 Global Autism Disorder Treatment Market Analysis, by Treatment Type, (2016-2025) ($MN)
Table 7 Global Autism Disorder Treatment Market Analysis, by Oxytocin therapy, (2016-2025) ($MN)
Table 8 Global Autism Disorder Treatment Market Analysis, by Hyperbaric oxygen therapy, (2016-2025) ($MN)
Table 9 Global Autism Disorder Treatment Market Analysis, by Chelation therapy, (2016-2025) ($MN)
Table 10 Global Autism Disorder Treatment Market Analysis, by ABA (applied behavioral analysis), (2016-2025) ($MN)
Table 11 Global Autism Disorder Treatment Market Analysis, by Other Treatment Types, (2016-2025) ($MN)
Table 12 Global Autism Disorder Treatment Market Analysis, by Drug, (2016-2025) ($MN)
Table 13 Global Autism Disorder Treatment Market Analysis, by Stimulants, (2016-2025) ($MN)
Table 14 Global Autism Disorder Treatment Market Analysis, by Selective Serotonin Reuptake Inhibitors (SSRIs), (2016-2025) ($MN)
Table 15 Global Autism Disorder Treatment Market Analysis, by Anti-Convulsants, (2016-2025) ($MN)
Table 16 Global Autism Disorder Treatment Market Analysis, by Anti-Psychotic, (2016-2025) ($MN)
Table 17 Global Autism Disorder Treatment Market Analysis, by Risperidone, (2016-2025) ($MN)
Table 18 Global Autism Disorder Treatment Market Analysis, by Abilify (aripiprazole), (2016-2025) ($MN)
Table 19 North America Autism Disorder Treatment Market Analysis, by Country, (2016-2025) ($MN)
Table 20 North America Autism Disorder Treatment Market Analysis, by Type, (2016-2025) ($MN)
Table 21 North America Autism Disorder Treatment Market Analysis, by Pervasive Developmental Disorder, (2016-2025) ($MN)
Table 22 North America Autism Disorder Treatment Market Analysis, by Asperger Syndrome, (2016-2025) ($MN)
Table 23 North America Autism Disorder Treatment Market Analysis, by Other Types, (2016-2025) ($MN)
Table 24 North America Autism Disorder Treatment Market Analysis, by Treatment Type, (2016-2025) ($MN)
Table 25 North America Autism Disorder Treatment Market Analysis, by Oxytocin therapy, (2016-2025) ($MN)
Table 26 North America Autism Disorder Treatment Market Analysis, by Hyperbaric oxygen therapy, (2016-2025) ($MN)
Table 27 North America Autism Disorder Treatment Market Analysis, by Chelation therapy, (2016-2025) ($MN)
Table 28 North America Autism Disorder Treatment Market Analysis, by ABA (applied behavioral analysis), (2016-2025) ($MN)
Table 29 North America Autism Disorder Treatment Market Analysis, by Other Treatment Types, (2016-2025) ($MN)
Table 30 North America Autism Disorder Treatment Market Analysis, by Drug, (2016-2025) ($MN)
Table 31 North America Autism Disorder Treatment Market Analysis, by Stimulants, (2016-2025) ($MN)
Table 32 North America Autism Disorder Treatment Market Analysis, by Selective Serotonin Reuptake Inhibitors (SSRIs), (2016-2025) ($MN)
Table 33 North America Autism Disorder Treatment Market Analysis, by Anti-Convulsants, (2016-2025) ($MN)
Table 34 North America Autism Disorder Treatment Market Analysis, by Anti-Psychotic, (2016-2025) ($MN)
Table 35 North America Autism Disorder Treatment Market Analysis, by Risperidone, (2016-2025) ($MN)
Table 36 North America Autism Disorder Treatment Market Analysis, by Abilify (aripiprazole), (2016-2025) ($MN)
Table 37 Europe Autism Disorder Treatment Market Analysis, by Country, (2016-2025) ($MN)
Table 38 Europe Autism Disorder Treatment Market Analysis, by Type, (2016-2025) ($MN)
Table 39 Europe Autism Disorder Treatment Market Analysis, by Pervasive Developmental Disorder, (2016-2025) ($MN)
Table 40 Europe Autism Disorder Treatment Market Analysis, by Asperger Syndrome, (2016-2025) ($MN)
Table 41 Europe Autism Disorder Treatment Market Analysis, by Other Types, (2016-2025) ($MN)
Table 42 Europe Autism Disorder Treatment Market Analysis, by Treatment Type, (2016-2025) ($MN)
Table 43 Europe Autism Disorder Treatment Market Analysis, by Oxytocin therapy, (2016-2025) ($MN)
Table 44 Europe Autism Disorder Treatment Market Analysis, by Hyperbaric oxygen therapy, (2016-2025) ($MN)
Table 45 Europe Autism Disorder Treatment Market Analysis, by Chelation therapy, (2016-2025) ($MN)
Table 46 Europe Autism Disorder Treatment Market Analysis, by ABA (applied behavioral analysis), (2016-2025) ($MN)
Table 47 Europe Autism Disorder Treatment Market Analysis, by Other Treatment Types, (2016-2025) ($MN)
Table 48 Europe Autism Disorder Treatment Market Analysis, by Drug, (2016-2025) ($MN)
Table 49 Europe Autism Disorder Treatment Market Analysis, by Stimulants, (2016-2025) ($MN)
Table 50 Europe Autism Disorder Treatment Market Analysis, by Selective Serotonin Reuptake Inhibitors (SSRIs), (2016-2025) ($MN)
Table 51 Europe Autism Disorder Treatment Market Analysis, by Anti-Convulsants, (2016-2025) ($MN)
Table 52 Europe Autism Disorder Treatment Market Analysis, by Anti-Psychotic, (2016-2025) ($MN)
Table 53 Europe Autism Disorder Treatment Market Analysis, by Risperidone, (2016-2025) ($MN)
Table 54 Europe Autism Disorder Treatment Market Analysis, by Abilify (aripiprazole), (2016-2025) ($MN)
Table 55 Asia Pacific Autism Disorder Treatment Market Analysis, by Country, (2016-2025) ($MN)
Table 56 Asia Pacific Autism Disorder Treatment Market Analysis, by Type, (2016-2025) ($MN)
Table 57 Asia Pacific Autism Disorder Treatment Market Analysis, by Pervasive Developmental Disorder, (2016-2025) ($MN)
Table 58 Asia Pacific Autism Disorder Treatment Market Analysis, by Asperger Syndrome, (2016-2025) ($MN)
Table 59 Asia Pacific Autism Disorder Treatment Market Analysis, by Other Types, (2016-2025) ($MN)
Table 60 Asia Pacific Autism Disorder Treatment Market Analysis, by Treatment Type, (2016-2025) ($MN)
Table 61 Asia Pacific Autism Disorder Treatment Market Analysis, by Oxytocin therapy, (2016-2025) ($MN)
Table 62 Asia Pacific Autism Disorder Treatment Market Analysis, by Hyperbaric oxygen therapy, (2016-2025) ($MN)
Table 63 Asia Pacific Autism Disorder Treatment Market Analysis, by Chelation therapy, (2016-2025) ($MN)
Table 64 Asia Pacific Autism Disorder Treatment Market Analysis, by ABA (applied behavioral analysis), (2016-2025) ($MN)
Table 65 Asia Pacific Autism Disorder Treatment Market Analysis, by Other Treatment Types, (2016-2025) ($MN)
Table 66 Asia Pacific Autism Disorder Treatment Market Analysis, by Drug, (2016-2025) ($MN)
Table 67 Asia Pacific Autism Disorder Treatment Market Analysis, by Stimulants, (2016-2025) ($MN)
Table 68 Asia Pacific Autism Disorder Treatment Market Analysis, by Selective Serotonin Reuptake Inhibitors (SSRIs), (2016-2025) ($MN)
Table 69 Asia Pacific Autism Disorder Treatment Market Analysis, by Anti-Convulsants, (2016-2025) ($MN)
Table 70 Asia Pacific Autism Disorder Treatment Market Analysis, by Anti-Psychotic, (2016-2025) ($MN)
Table 71 Asia Pacific Autism Disorder Treatment Market Analysis, by Risperidone, (2016-2025) ($MN)
Table 72 Asia Pacific Autism Disorder Treatment Market Analysis, by Abilify (aripiprazole), (2016-2025) ($MN)
Table 73 South America Autism Disorder Treatment Market Analysis, by Country, (2016-2025) ($MN)
Table 74 South America Autism Disorder Treatment Market Analysis, by Type, (2016-2025) ($MN)
Table 75 South America Autism Disorder Treatment Market Analysis, by Pervasive Developmental Disorder, (2016-2025) ($MN)
Table 76 South America Autism Disorder Treatment Market Analysis, by Asperger Syndrome, (2016-2025) ($MN)
Table 77 South America Autism Disorder Treatment Market Analysis, by Other Types, (2016-2025) ($MN)
Table 78 South America Autism Disorder Treatment Market Analysis, by Treatment Type, (2016-2025) ($MN)
Table 79 South America Autism Disorder Treatment Market Analysis, by Oxytocin therapy, (2016-2025) ($MN)
Table 80 South America Autism Disorder Treatment Market Analysis, by Hyperbaric oxygen therapy, (2016-2025) ($MN)
Table 81 South America Autism Disorder Treatment Market Analysis, by Chelation therapy, (2016-2025) ($MN)
Table 82 South America Autism Disorder Treatment Market Analysis, by ABA (applied behavioral analysis), (2016-2025) ($MN)
Table 83 South America Autism Disorder Treatment Market Analysis, by Other Treatment Types, (2016-2025) ($MN)
Table 84 South America Autism Disorder Treatment Market Analysis, by Drug, (2016-2025) ($MN)
Table 85 South America Autism Disorder Treatment Market Analysis, by Stimulants, (2016-2025) ($MN)
Table 86 South America Autism Disorder Treatment Market Analysis, by Selective Serotonin Reuptake Inhibitors (SSRIs), (2016-2025) ($MN)
Table 87 South America Autism Disorder Treatment Market Analysis, by Anti-Convulsants, (2016-2025) ($MN)
Table 88 South America Autism Disorder Treatment Market Analysis, by Anti-Psychotic, (2016-2025) ($MN)
Table 89 South America Autism Disorder Treatment Market Analysis, by Risperidone, (2016-2025) ($MN)
Table 90 South America Autism Disorder Treatment Market Analysis, by Abilify (aripiprazole), (2016-2025) ($MN)
Table 91 Middle East & Africa Autism Disorder Treatment Market Analysis, by Country, (2016-2025) ($MN)
Table 92 Middle East & Africa Autism Disorder Treatment Market Analysis, by Type, (2016-2025) ($MN)
Table 93 Middle East & Africa Autism Disorder Treatment Market Analysis, by Pervasive Developmental Disorder, (2016-2025) ($MN)
Table 94 Middle East & Africa Autism Disorder Treatment Market Analysis, by Asperger Syndrome, (2016-2025) ($MN)
Table 95 Middle East & Africa Autism Disorder Treatment Market Analysis, by Other Types, (2016-2025) ($MN)
Table 96 Middle East & Africa Autism Disorder Treatment Market Analysis, by Treatment Type, (2016-2025) ($MN)
Table 97 Middle East & Africa Autism Disorder Treatment Market Analysis, by Oxytocin therapy, (2016-2025) ($MN)
Table 98 Middle East & Africa Autism Disorder Treatment Market Analysis, by Hyperbaric oxygen therapy, (2016-2025) ($MN)
Table 99 Middle East & Africa Autism Disorder Treatment Market Analysis, by Chelation therapy, (2016-2025) ($MN)
Table 100 Middle East & Africa Autism Disorder Treatment Market Analysis, by ABA (applied behavioral analysis), (2016-2025) ($MN)
Table 101 Middle East & Africa Autism Disorder Treatment Market Analysis, by Other Treatment Types, (2016-2025) ($MN)
Table 102 Middle East & Africa Autism Disorder Treatment Market Analysis, by Drug, (2016-2025) ($MN)
Table 103 Middle East & Africa Autism Disorder Treatment Market Analysis, by Stimulants, (2016-2025) ($MN)
Table 104 Middle East & Africa Autism Disorder Treatment Market Analysis, by Selective Serotonin Reuptake Inhibitors (SSRIs), (2016-2025) ($MN)
Table 105 Middle East & Africa Autism Disorder Treatment Market Analysis, by Anti-Convulsants, (2016-2025) ($MN)
Table 106 Middle East & Africa Autism Disorder Treatment Market Analysis, by Anti-Psychotic, (2016-2025) ($MN)
Table 107 Middle East & Africa Autism Disorder Treatment Market Analysis, by Risperidone, (2016-2025) ($MN)
Table 108 Middle East & Africa Autism Disorder Treatment Market Analysis, by Abilify (aripiprazole), (2016-2025) ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report